About this trial
This prospective observational study aims to evaluate the risk factors, clinical course, and outcomes among children with acute hepatitis A infection admitted to Assiut University Children Hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 1 month to 18 years
Confirmed acute hepatitis A infection by positive Anti-HAV IgM
Written informed consent from parents or legal guardians
Disqualifiers
- Co-infection with hepatitis B, hepatitis C, or hepatitis E
Chronic liver diseases (autoimmune hepatitis, Wilson disease, metabolic liver diseases)
Trial population
Children with confirmed acute hepatitis A infection admitted to or presenting at Assiut University Children Hospital.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Proportion of children with unfavorable outcome
Proportion of children who develop one or more of the following during hospital stay: acute liver failure, hepatic encephalopathy, acute kidney injury, ICU admission, prolonged hospital stay (\>7 days), or death.
Secondary outcomes
Proportion of children with acute liver failure
Proportion of children who develop acute liver failure during hospital stay.
Proportion of children with hepatic encephalopathy
Proportion of children who develop hepatic encephalopathy (any West Haven grade) during hospital stay.
Mean duration of hospital stay
Mean number of days of hospitalization.
Proportion of children requiring ICU admission
Proportion of children who require intensive care unit admission.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: